Mindfulness Meditation in Bone Marrow Transplantation
Study Details
Study Description
Brief Summary
The main purpose of this study is to examine techniques to help patients cope better with the stem cell/bone marrow transplant procedure.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 2/Phase 3 |
Detailed Description
Patients will be assigned to one of three study groups:
-
receives the normal standard care;
-
meets with an oncology nurse educator, in addition to the regular nurses on the transplant team. The nurse educator will provide information and answers to patient's questions about the stem cell/bone marrow transplant experience; or
-
is taught mindfulness meditation by a nurse who is trained to be a mindfulness instructor and by an audio CD.
Mindfulness meditation is a technique that may help in coping with the stress and difficulties associated with cancer and undergoing a stem cell/bone marrow transplant. It involves learning to be in the present moment by paying attention to your breathing, sights, and sounds, and to sensations you may be experiencing, or thoughts and feelings you may be having.
Mindfulness meditation has been shown to be helpful to patients in the clinic who have cancer and other medical conditions.
Patients, regardless of random group assignment, will complete a questionnaire 8 different times, from before they are admitted to the hospital until 6 months after discharge.
Patients will also provide two urine samples while in the hospital to measure the levels of stress hormones present in the urine.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
No Intervention: Usual Care Normal standard of care |
|
Active Comparator: Nurse education Meets with oncology nurse |
Behavioral: Nurse education
Meets with oncology nurse to have questions answered about medical treatments and side effects
|
Experimental: Mindfulness training Taught Mindfulness meditation |
Behavioral: Mindfulness training
Taught mindfulness meditation by mindfulness instructor (trained health care professional/RN) and audio c/d
|
Outcome Measures
Primary Outcome Measures
- Psychological functioning [1 year]
Secondary Outcome Measures
- Number of days to bone marrow engraftment [1 year]
- Medication use [1 year]
- Urinary stress hormones (cortisol and catecholamines) [1 year]
- Transplant related complications [1 year]
- Hospital length of stay and re-hospitalizations [1 year]
- Physical symptoms [1 year]
- Quality of life [1 year]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Autologous stem cell transplantation for hematologic malignancy
-
First transplant
-
21 years of age or older
-
Speaks and understands English
Exclusion Criteria:
-
Planned tandem (more than one) transplant
-
Taking corticosteroids on a regular basis for a chronic condition
-
Prior formal mindfulness meditation training
-
Significant cognitive impairment and/or confirmed psychosis or thought disorder
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Emory University | Atlanta | Georgia | United States | |
2 | Dana-Farber Cancer Institute | Boston | Massachusetts | United States | 02115 |
3 | University of Massachusetts Medical School | Worcester | Massachusetts | United States | 01655 |
Sponsors and Collaborators
- Emory University
- Dana-Farber Cancer Institute
- University of Massachusetts, Worcester
Investigators
- Principal Investigator: Susan Bauer-Wu, PhD, Emory University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- IRB00005285